The spatial folding of chromosomes inside the nucleus has regulatory effects on gene expression, yet the impact of genome reshuffling on this organization remains unclear. Here, we take advantage of chromosome conformation capture in combination with single-nucleotide polymorphism (SNP) genotyping and analysis of crossover events to study how the higher-order chromatin organization and recombination landscapes are affected by chromosomal fusions in the mammalian germ line.

 

We demonstrate that chromosomal fusions alter the nuclear architecture during meiosis, including an increased rate of heterologous interactions in primary spermatocytes, and alterations in both chromosome synapsis and axis length.

 

These disturbances in topology were associated with changes in genomic landscapes of recombination, resulting in detectable genomic footprints. Overall, we show that chromosomal fusions impact the dynamic genome topology of germ cells in two ways: (i) altering chromosomal nuclear occupancy and synapsis, and (ii) reshaping landscapes of recombination.

 

Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of HNSCC with or without HPV infection

Head and neck squamous cell carcinoma (HNSCC) are the sixth most common cancer type in the world. Human papillomavirus (HPV) infection is an emerging risk factor for HNSCC. Immune infiltration of HNSCC is linked to therapeutic results. This article aimed to decide whether variations in HPV status affect immune infiltration, molecular mechanism, and how these results vary in HNSCC patients.

 

We investigated the tumor-infiltrating immune cells (TIICs) and immune-related gene differences between HPV (+) and HPV (-) HNSCC. The gene expression quantification data of HNSCC and their clinical information were download from the TCGA database. Immune-related genes have been linked to the ImmPort platform.

 

After analyzed of 22 TIICs in the HNSCC tumor environment by CIBERSORT and further assessment, lower memory B cell and higher T cell regulatory were connected with better HPV (-) HNSCC outcome, higher activated memory CD4 T cell, higher T cell regulatory, and lower activated NK cell were linked with better HPV (+) result.

 

We finally got five forms of immune genes (CAMP, EDNRB, NTS, CXCL9, LHB) associated with HNSCC progression. Higher expressions of CAMP, EDNRB, and NTS were associated with increased overall survival in HPV (-) patients. Higher expression of CXCL9 and lower expression of LHB contributed to increased overall survival of HPV (+) patients.

 

There tend to be discrepancies in the cell structure of TIICs and immune-related genes in HPV (-) and HPV (+) HNSCC. These variances are typically too crucial for the therapeutic outcome of the patient and the development of the tumor. In specific, our sample established these candidate immune cells and immune-related genes as candidate reservoirs for further researches.

Multi-ancestry genome-wide association study identifies 27 loci associated with measures of hemolysis following blood storage

The evolutionary pressure of endemic malaria and other erythrocytic pathogens has shaped variation in genes encoding erythrocyte structural and functional proteins, influencing responses to hemolytic stress during transfusion and disease.

 

We sought to identify such genetic variants in blood donors by conducting a genome-wide association study (GWAS) of 12,353 volunteer donors, including 1,483 African Americans, 1,477 Asians, and 960 Hispanics, whose stored erythrocytes were characterized by quantitative assays of in vitro osmotic, oxidative, and cold-storage hemolysis.

GWAS revealed 27 significant loci (p<5×10-8), many in candidate genes known to modulate erythrocyte structure, metabolism, and ion channels, including SPTA1, ALDH2, ANK1, HK1, MAPKAPK5, AQP1, PIEZO1, and SLC4A1/Band 3. GWAS of oxidative hemolysis identified variants in antioxidant enzymes including GLRX, GPX4, G6PD, and a novel golgi-transport protein SEC14L4.

 

Genome wide significant loci were also tested for association with the severity of steady state (baseline) in vivo hemolytic anemia in patients with sickle cell disease, with confirmation of identified SNPs in HBA2, G6PD, PIEZO1, AQP1 and SEC14L4. Many of the identified variants, such as those in G6PD, have previously been shown to impair erythrocyte recovery after transfusion, associate with anemia, or cause rare Mendelian human hemolytic diseases.

Candidate SNPs in these genes, especially in polygenic combinations, may affect RBC recovery after transfusion and modulate disease severity in hemolytic diseases, such as sickle cell disease and malaria.

Incorporating Genomic and Genetic Testing into the Treatment of Metastatic Luminal Breast Cancer

Background: Treatment of patients with luminal metastatic breast cancer (MBC) has become even more complex over the last few years as molecular profiling has begun to alter disease management. It is well accepted that MBC is not curable but is treatable. Today we are able to prolong progression-free survival and partly overall survival with targeted and more individual treatment strategies adjusted according to the molecular subtype.

Summary: Genetic and genomic testing has become therapeutically relevant in luminal MBC and is therefore an integral component within the treatment spectrum. By now, germline testing of BRCABRCAPIK3CA mutations are inevitable elements in disease management and the current state of the art in luminal MBC patients.

Furthermore, testing of ESR1 resistance mutation, ERBB2 mutation, microsatellite instability, and neurotrophic tyrosine receptor kinase (NTRK) gene fusion (mainly in secretory breast cancer) has recently gained increasing attention. However, based on the expanding role of personalized medicine, clinicians are now faced with substantial new challenges and possibly unsuspected possibilities. The following review summarizes current developments in genetic and genomic testing in luminal MBC.

Key messages: In luminal MBC genomics have become an integral component within the spectrum of oncological treatment establishing novel therapeutic facilities. Further developments in treatment personalization adjusted according to the molecular subtype should become increasingly important in order to enhance the progress of de-escalation of chemotherapy in luminal MBC. However, based on the expanding role of personalized medicine, clinicians are now faced with substantial new challenges and possibly unsuspected possibilities.

 

HIV-P24 antigen array kit
VArk-Lsx001	Creative Biolabs	unit	Ask for price
Description: Fourth-generation HIV immunoassays detect viral p24 protein in the blood.

HIV-1 p17-p24 recombinant antigen.
00172-V-100ugvial	Virogen	100ug/vial	EUR 150
Description: HIV-1 p17-p24 recombinant antigen.

HIV-1 GAG P24 Recombinant Antigen
00111-V-01mg	Virogen	0,1 mg	EUR 321
Description: HIV-1 gag p24 recombinant antigen a.a 77 to a.a 436 of the HIV-1 gag region 39 kDa

HIV-1 GAG P24 Recombinant Antigen
00111-V-1000ug	Virogen	1000 ug	EUR 1539
Description: HIV-1 gag p24 recombinant antigen a.a 77 to a.a 436 of the HIV-1 gag region 39 kDa

HIV 1 p24 core recombinant antigen
00177-V-01mg	Virogen	0,1 mg	EUR 321
Description: HIV 1 p24 core recombinant antigen.

HIV 1 p24 core recombinant antigen
00177-V-1000ug	Virogen	1000 ug	EUR 1539
Description: HIV 1 p24 core recombinant antigen.

HIV 1 p24 core recombinant antigen.
00177-V-100ugvial	Virogen	100ug/vial	EUR 150
Description: HIV 1 p24 core recombinant antigen.

HIV Type 1 p24 Antigen ELISA (5 X 96 Determinations)
0801200	Zeptometrix	5 X 96T	EUR 2563

HIV Type 1 p24 Antigen ELISA (5 X 96 Determinations)
801200	Zeptometrix	5 X 96 Determinations	EUR 2330

HIV Type 1 p24 Antigen ELISA 2.0 (5 X 96 Determinations)
801008	Zeptometrix	5 X 96 Determinations	EUR 2386

HIV Type 1 p24 Antigen ELISA 2.0 (5 X 96 Determinations)
0801008	Zeptometrix	5 X 96T	EUR 2505

Human HIV(1+2 antibodies plus p24 antigen (4th Generation) ELISA Kit
EH4101	FN Test	96T	EUR 571.5
Description: Method of detection: Qualitative ;Reacts with: Homo sapiens;Sensitivity: Qualitative

HIV-1 p24 ELISA Kit
Z7040001	Biochain	1 kit	EUR 752

HIV-1 gag p24 recombinant antigen a.a 77 to a.a 436 of the HIV-1 gag region 39 kDa
00111-V-100ugvial	Virogen	100ug/vial	EUR 150
Description: HIV-1 gag p24 recombinant antigen a.a 77 to a.a 436 of the HIV-1 gag region 39 kDa

HIV-1 p17/24/gp120 antigen
00169-V-01mg	Virogen	0,1 mg	EUR 321
Description: HIV-1 p17/24/gp120 antigen.The protein contains the HIV immunodominant regions from gag p17-p24 gp 120.

HIV-1 p17/24/gp120 antigen
00169-V-1000ug	Virogen	1000 ug	EUR 1539
Description: HIV-1 p17/24/gp120 antigen.The protein contains the HIV immunodominant regions from gag p17-p24 gp 120.

HIV-1 intergase antigen
00199-V-01mg	Virogen	0,1 mg	EUR 321
Description: HIV-1 intergase antigen. The protein contains the HIV-1 immunodominant regions from pol protein (integrase).

HIV-1 intergase antigen
00199-V-1000ug	Virogen	1000 ug	EUR 1539
Description: HIV-1 intergase antigen. The protein contains the HIV-1 immunodominant regions from pol protein (integrase).

HIV-1 p24 Antibody
20-abx137062	Abbexa	EUR 427.20 EUR 627.60	0.5 mg 1 mg

HIV-1 p24 Antibody
7313-002mg	ProSci	0.02 mg	EUR 206.18
Description: HIV-1 p24 Antibody: The human immunodeficiency virus type 1 (HIV-1) particle consists of an envelope, a core and the region between the two termed matrix. The HIV-1 Gag protein is a late structural protein that contains four proteins: matrix (p17), capsid (p24), nucleocapsid (p7) and the p6 protein. The p24 is the major capsid protein of the virus and has been used in clinical trials as one of the components of the HIV-1 vaccine because of the high degree of sequence conservation between different strains.

HIV-1 p24 Antibody
7313-01mg	ProSci	0.1 mg	EUR 523.7
Description: HIV-1 p24 Antibody: The human immunodeficiency virus type 1 (HIV-1) particle consists of an envelope, a core and the region between the two termed matrix. The HIV-1 Gag protein is a late structural protein that contains four proteins: matrix (p17), capsid (p24), nucleocapsid (p7) and the p6 protein. The p24 is the major capsid protein of the virus and has been used in clinical trials as one of the components of the HIV-1 vaccine because of the high degree of sequence conservation between different strains.

HIV-1 p24 Antibody
abx021869-1mg	Abbexa	1 mg	EUR 794.4

HIV-1 p24 Antibody
abx021870-1mg	Abbexa	1 mg	EUR 760.8

HIV-1 p24 Antibody
abx021871-1mg	Abbexa	1 mg	EUR 794.4

HIV-1 p24 Antibody
abx021872-1mg	Abbexa	1 mg	EUR 794.4

HIV-1 p24 Antibody
abx021873-1mg	Abbexa	1 mg	EUR 794.4

HIV-1 p24 Antibody
abx021882-1mg	Abbexa	1 mg	EUR 1178.4

HIV-1 p24 Antibody
abx021883-1mg	Abbexa	1 mg	EUR 1220.4

HIV-1 p24 Antibody
abx021886-1mg	Abbexa	1 mg	EUR 1220.4

HIV-1 p24 Antibody
abx021887-1mg	Abbexa	1 mg	EUR 1220.4

HIV-1 p24 Antibody
abx021888-1mg	Abbexa	1 mg	EUR 1220.4

HIV-1 p24 Antibody
abx023027-1ml	Abbexa	1 ml	EUR 693.6

HIV-1 p24 Antibody
abx023925-1mg	Abbexa	1 mg	EUR 828

HIV-1 p24 Antibody
abx023926-1mg	Abbexa	1 mg	EUR 828

HIV-1 p24
E5-00024	EnoGene	1mg	EUR 1152

HIV-1 p24
E62H002	EnoGene	100ug	EUR 458.4

HIV-1 tat recombinant antigen
00110-V-01mg	Virogen	0,1 mg	EUR 321
Description: HIV-1 tat recombinant antigen full length 15 kDa

HIV-1 tat recombinant antigen
00110-V-1000ug	Virogen	1000 ug	EUR 1539
Description: HIV-1 tat recombinant antigen full length 15 kDa

HIV-1 nef recombinant antigen
00112-V-01mg	Virogen	0,1 mg	EUR 321
Description: HIV-1 nef recombinant antigen a.a 3 to a.a 190 of the HIV-1 nef region 20 kDa

HIV-1 nef recombinant antigen
00112-V-1000ug	Virogen	1000 ug	EUR 1539
Description: HIV-1 nef recombinant antigen a.a 3 to a.a 190 of the HIV-1 nef region 20 kDa

HIV-1 gag recombinant antigen
8934	Virostat	100 ug	EUR 542.86
Description: This is HIV-1 gag recombinant antigen for ELISA,WB.

HIV-1 nef recombinant antigen
8941	Virostat	100 ug	EUR 477.6
Description: This is HIV-1 nef recombinant antigen for ELISA,WB.

HIV-1 gp41 recombinant antigen,
00170-V-01mg	Virogen	0,1 mg	EUR 321
Description: HIV-1 gp41 recombinant antigen.

HIV-1 gp41 recombinant antigen,
00170-V-1000ug	Virogen	1000 ug	EUR 1539
Description: HIV-1 gp41 recombinant antigen.

HIV-1 gp41 recombinant antigen
8908	Virostat	100 ug	EUR 673.36
Description: This is HIV-1 gp41 recombinant antigen for ELISA,WB.

HIV-1 gp41 recombinant antigen
8933	Virostat	100 ug	EUR 477.6
Description: This is HIV-1 gp41 recombinant antigen for ELISA,WB.

HIV-1 gp41 recombinant antigen
9000	Virostat	100 ug	EUR 484.13
Description: This is HIV-1 gp41 recombinant antigen for ELISA,WB.

HIV-1 gp41 recombinant antigen
9001	Virostat	100 ug	EUR 484.13
Description: This is HIV-1 gp41 recombinant antigen for ELISA,WB.

HIV-1 gp41 recombinant antigen.
00170-V-100ugvial	Virogen	100ug/vial	EUR 150
Description: HIV-1 gp41 recombinant antigen.

HIV p24 Antibody
abx021867-1mg	Abbexa	1 mg	EUR 1612.8

HIV p24 Antibody
abx021868-1mg	Abbexa	1 mg	EUR 1612.8

HIV-1 p17/24/gp120-gp41 recombinant antigen,
00168-V-01mg	Virogen	0,1 mg	EUR 321
Description: HIV-1 p17/24/gp120-gp41 recombinant antigen.

HIV-1 p17/24/gp120-gp41 recombinant antigen,
00168-V-1000ug	Virogen	1000 ug	EUR 1539
Description: HIV-1 p17/24/gp120-gp41 recombinant antigen.

HIV-1 p17/24/gp120-gp41 recombinant antigen.
00168-V-100ugvial	Virogen	100ug/vial	EUR 150
Description: HIV-1 p17/24/gp120-gp41 recombinant antigen.

HIV 1 envelope recombinant antigen
00176-V-01mg	Virogen	0,1 mg	EUR 321
Description: HIV 1 envelope recombinant antigen. HIV-1 evnelope protein spanning the C-Terminus of gp 120 and most of gp 41.

HIV 1 envelope recombinant antigen
00176-V-1000ug	Virogen	1000 ug	EUR 1539
Description: HIV 1 envelope recombinant antigen. HIV-1 evnelope protein spanning the C-Terminus of gp 120 and most of gp 41.

ToX Antigen (P24,GRA1)
E61Y00305	EnoGene	1mg	EUR 840

HIV-1 p24 Antibody (HRP)
abx023029-1ml	Abbexa	1 ml	EUR 886.8

HIV-1 p24 Antibody [8G9]
PM-6335-002mg	ProSci	0.02 mg	EUR 206.18
Description: HIV-1 p24 Monoclonal Antibody: The human immunodeficiency virus type 1 (HIV-1) particle consists of an envelope, a core and the region between the two termed matrix (1). The HIV-1 Gag protein is a late structural protein that contains four proteins: matrix (p17), capsid (p24), nucleocapsid (p7) and the p6 protein (2). The p24 constitutes the major core component of the virus and shows high degree of sequence conservation among HIV isolates. The Gag p24 has been used as an integral part of multicomponent HIV-1 vaccines (3).

HIV-1 p24 Antibody [8G9]
PM-6335-01mg	ProSci	0.1 mg	EUR 523.7
Description: HIV-1 p24 Monoclonal Antibody: The human immunodeficiency virus type 1 (HIV-1) particle consists of an envelope, a core and the region between the two termed matrix (1). The HIV-1 Gag protein is a late structural protein that contains four proteins: matrix (p17), capsid (p24), nucleocapsid (p7) and the p6 protein (2). The p24 constitutes the major core component of the virus and shows high degree of sequence conservation among HIV isolates. The Gag p24 has been used as an integral part of multicomponent HIV-1 vaccines (3).

HIV-1 p24 Antibody [7F4]
PM-6585-002mg	ProSci	0.02 mg	EUR 206.18
Description: HIV-1 p24 Monoclonal Antibody: The human immunodeficiency virus type 1 (HIV-1) particle consists of an envelope, a core and the region between the two termed matrix (1). The HIV-1 Gag protein is a late structural protein that contains four proteins: matrix (p17), capsid (p24), nucleocapsid (p7) and the p6 protein (2). The p24 constitutes the major core component of the virus and shows high degree of sequence conservation among HIV isolates. The Gag p24 has been used as an integral part of multicomponent HIV-1 vaccines (3).

HIV-1 p24 Antibody [7F4]
PM-6585-01mg	ProSci	0.1 mg	EUR 523.7
Description: HIV-1 p24 Monoclonal Antibody: The human immunodeficiency virus type 1 (HIV-1) particle consists of an envelope, a core and the region between the two termed matrix (1). The HIV-1 Gag protein is a late structural protein that contains four proteins: matrix (p17), capsid (p24), nucleocapsid (p7) and the p6 protein (2). The p24 constitutes the major core component of the virus and shows high degree of sequence conservation among HIV isolates. The Gag p24 has been used as an integral part of multicomponent HIV-1 vaccines (3).

HIV-1 env gp41 recombinant antigen
00113-V-01mg	Virogen	0,1 mg	EUR 321
Description: HIV-1 env gp41 recombinant antigen a.a 466 to a.a 753 of the HIV-1 env region 32 kDa

HIV-1 env gp41 recombinant antigen
00113-V-1000ug	Virogen	1000 ug	EUR 1539
Description: HIV-1 env gp41 recombinant antigen a.a 466 to a.a 753 of the HIV-1 env region 32 kDa

HIV-1 p24 Antibody (FITC)
abx021884-100ug	Abbexa	100 ug	EUR 886.8

HIV-1 p24 Antibody (FITC)
abx023026-1ml	Abbexa	1 ml	EUR 678

HIV 1 / 2 p24 Antibody
abx021866-1mg	Abbexa	1 mg	EUR 1212

HIV 1 / 2 p24 Antibody
abx021890-1mg	Abbexa	1 mg	EUR 1212

HIV-1 gp41 Long recombinant antigen,
00171-V-01mg	Virogen	0,1 mg	EUR 321
Description: HIV-1 gp41 Long recombinant antigen.

HIV-1 gp41 Long recombinant antigen,
00171-V-1000ug	Virogen	1000 ug	EUR 1539
Description: HIV-1 gp41 Long recombinant antigen.

HIV-1 gp41 Long recombinant antigen.
00171-V-100ugvial	Virogen	100ug/vial	EUR 150
Description: HIV-1 gp41 Long recombinant antigen.

HIV-1 p24 Antibody (Biotin)
abx023028-1ml	Abbexa	1 ml	EUR 794.4

Polyclonal HIV-1 p24 Antibody
APR11116G	Leading Biology	0.1 mg	EUR 790.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human HIV-1 p24 . This antibody is tested and proven to work in the following applications:

HIV-1 p24 Protein
20-abx261886	Abbexa	EUR 5388.00 EUR 393.60 EUR 276.00	1 mg 20 ug 5 ug

HIV-1 p24 Protein
abx169032-1mg	Abbexa	1 mg	EUR 661.2

HIV-1 p24 Protein
abx061424-05mg	Abbexa	0.5 mg	EUR 886.8

HIV-1, p24 Protein
abx069857-1mg	Abbexa	1 mg	EUR 1888.8

HIV-1 Gag p24
05-005	Sceti	50 ug	EUR 434.4
Description: The HIV-1 Gag p24 is available in Europe and for worldwide shipping via Gentaur.

HIV-1 Gag p24
05-006	Sceti	250 ug	EUR 1154.4
Description: The HIV-1 Gag p24 is available in Europe and for worldwide shipping via Gentaur.

Recombinant HIV-1 p24
7-07603	CHI Scientific	100µg	Ask for price

Recombinant HIV-1 p24
7-07604	CHI Scientific	500µg	Ask for price

Recombinant HIV-1 p24
7-07605	CHI Scientific	1000µg	Ask for price

HIV 1 p24 Protein
abx060589-1mg	Abbexa	1 mg	EUR 1545.6

HIV-1 p17/24/gp120 antigen.The protein contains the HIV immunodominant regions from gag p17-p24 gp 120.
00169-V-100ugvial	Virogen	100ug/vial	EUR 150
Description: HIV-1 p17/24/gp120 antigen.The protein contains the HIV immunodominant regions from gag p17-p24 gp 120.

HIV 1, 2 envelope recombinant antigen
00175-V-01mg	Virogen	0,1 mg	EUR 321
Description: HIV 1, 2 envelope recombinant antigen. HIV-1 envelope conjugated to HIV-2 envelope peptide.

HIV 1, 2 envelope recombinant antigen
00175-V-1000ug	Virogen	1000 ug	EUR 1539
Description: HIV 1, 2 envelope recombinant antigen. HIV-1 envelope conjugated to HIV-2 envelope peptide.

HIV-1 reverse transcriptase recombinant antigen
00198-V-01mg	Virogen	0,1 mg	EUR 321
Description: HIV-1 reverse transcriptase recombinant antigen.

HIV-1 reverse transcriptase recombinant antigen
00198-V-1000ug	Virogen	1000 ug	EUR 1539
Description: HIV-1 reverse transcriptase recombinant antigen.

HIV-1 reverse transcriptase recombinant antigen.
00198-V-100ugvial	Virogen	100ug/vial	EUR 150
Description: HIV-1 reverse transcriptase recombinant antigen.

Feline Immunodeficiency Virus p24 Antigen (FIV p24) Antibody
abx411336-02mg	Abbexa	0.2 mg	EUR 710.4

Feline Immunodeficiency Virus p24 Antigen (FIV p24) Antibody
abx412988-2ml	Abbexa	2 ml	EUR 727.2

HIV Type-1 p24 Antibody
V2344-100UG	NSJ Bioreagents	100 ug	EUR 349.3
Description: Human immunodeficiency virus (HIV) is a retrovirus that causes acquired immune deficiency syndrome (AIDS), a condition in humans in which the immune system begins to fail, leading to life-threatening opportunistic infections. HIV mainly infects vital cells in the human immune system such as helper T cells (specifically CD4+ T cells), macrophages and dendritic cells. Two species of HIV infect humans: HIV-1 and HIV-2, with HIV-1 being the more virulent strain. The gag gene of human immunodeficiency virus 1 (HIV-1) encodes a precursor protein known as Pr55Gag. The viral protease PR cleaves this precursor to generate p17, p24, p7, and p6 proteins, which are required for virus particle assembly. HIV-1 Gag p24 is a capsid protein that constitutes the core of AIDS virus HIV-1. p6 and p7 are the components of the nucleocapsid, and p17 provides a protective matrix. HIV-1 Gag p24 is indispensable to the reproduction of AIDS virus and constitutes an essential element for the AIDS virus particle construction. As this protein is detectable from the early stage of AIDS virus infection, its measurement is commonly used as an indicator of HIV-1 infection and viral load.

HIV Type-1 p24 Antibody
V2344-20UG	NSJ Bioreagents	20 ug	EUR 153.3
Description: Human immunodeficiency virus (HIV) is a retrovirus that causes acquired immune deficiency syndrome (AIDS), a condition in humans in which the immune system begins to fail, leading to life-threatening opportunistic infections. HIV mainly infects vital cells in the human immune system such as helper T cells (specifically CD4+ T cells), macrophages and dendritic cells. Two species of HIV infect humans: HIV-1 and HIV-2, with HIV-1 being the more virulent strain. The gag gene of human immunodeficiency virus 1 (HIV-1) encodes a precursor protein known as Pr55Gag. The viral protease PR cleaves this precursor to generate p17, p24, p7, and p6 proteins, which are required for virus particle assembly. HIV-1 Gag p24 is a capsid protein that constitutes the core of AIDS virus HIV-1. p6 and p7 are the components of the nucleocapsid, and p17 provides a protective matrix. HIV-1 Gag p24 is indispensable to the reproduction of AIDS virus and constitutes an essential element for the AIDS virus particle construction. As this protein is detectable from the early stage of AIDS virus infection, its measurement is commonly used as an indicator of HIV-1 infection and viral load.

HIV Type-1 p24 Antibody
V2344CF488-100T	NSJ Bioreagents	100 Tests	EUR 349.3
Description: Human immunodeficiency virus (HIV) is a retrovirus that causes acquired immune deficiency syndrome (AIDS), a condition in humans in which the immune system begins to fail, leading to life-threatening opportunistic infections. HIV mainly infects vital cells in the human immune system such as helper T cells (specifically CD4+ T cells), macrophages and dendritic cells. Two species of HIV infect humans: HIV-1 and HIV-2, with HIV-1 being the more virulent strain. The gag gene of human immunodeficiency virus 1 (HIV-1) encodes a precursor protein known as Pr55Gag. The viral protease PR cleaves this precursor to generate p17, p24, p7, and p6 proteins, which are required for virus particle assembly. HIV-1 Gag p24 is a capsid protein that constitutes the core of AIDS virus HIV-1. p6 and p7 are the components of the nucleocapsid, and p17 provides a protective matrix. HIV-1 Gag p24 is indispensable to the reproduction of AIDS virus and constitutes an essential element for the AIDS virus particle construction. As this protein is detectable from the early stage of AIDS virus infection, its measurement is commonly used as an indicator of HIV-1 infection and viral load.

HIV Type-1 p24 Antibody
V2344SAF-100UG	NSJ Bioreagents	100 ug	EUR 349.3
Description: Human immunodeficiency virus (HIV) is a retrovirus that causes acquired immune deficiency syndrome (AIDS), a condition in humans in which the immune system begins to fail, leading to life-threatening opportunistic infections. HIV mainly infects vital cells in the human immune system such as helper T cells (specifically CD4+ T cells), macrophages and dendritic cells. Two species of HIV infect humans: HIV-1 and HIV-2, with HIV-1 being the more virulent strain. The gag gene of human immunodeficiency virus 1 (HIV-1) encodes a precursor protein known as Pr55Gag. The viral protease PR cleaves this precursor to generate p17, p24, p7, and p6 proteins, which are required for virus particle assembly. HIV-1 Gag p24 is a capsid protein that constitutes the core of AIDS virus HIV-1. p6 and p7 are the components of the nucleocapsid, and p17 provides a protective matrix. HIV-1 Gag p24 is indispensable to the reproduction of AIDS virus and constitutes an essential element for the AIDS virus particle construction. As this protein is detectable from the early stage of AIDS virus infection, its measurement is commonly used as an indicator of HIV-1 infection and viral load.

HIV-2 gp32 recombinant antigen
00173-V-01mg	Virogen	0,1 mg	EUR 321
Description: HIV-2 gp32 recombinant antigen. .

HIV-2 gp32 recombinant antigen
00173-V-1000ug	Virogen	1000 ug	EUR 1539
Description: HIV-2 gp32 recombinant antigen. .

HIV-2 gp36 recombinant antigen
8911	Virostat	100 ug	EUR 673.36
Description: This is HIV-2 gp36 recombinant antigen for ELISA,WB.

HIV-2 gp36 recombinant antigen
8949	Virostat	100 ug	EUR 529.8
Description: This is HIV-2 gp36 recombinant antigen for ELISA,WB.

HIV-2 gp36 recombinant antigen
9003	Virostat	100 ug	EUR 484.13
Description: This is HIV-2 gp36 recombinant antigen for ELISA,WB.

HIV-2 gp32 recombinant antigen. .
00173-V-100ugvial	Virogen	100ug/vial	EUR 150
Description: HIV-2 gp32 recombinant antigen. .

HIV type 1 P24
DAG1520	Creative Diagnostics	100 µg	EUR 972

HIV-1 p24 Antibody [8G9] (HRP)
PM-6335-HRP-002mg	ProSci	0.02 mg	EUR 206.18
Description: HIV-1 p24 Monoclonal Antibody: The human immunodeficiency virus type 1 (HIV-1) particle consists of an envelope, a core and the region between the two termed matrix (1). The HIV-1 Gag protein is a late structural protein that contains four proteins: matrix (p17), capsid (p24), nucleocapsid (p7) and the p6 protein (2). The p24 constitutes the major core component of the virus and shows high degree of sequence conservation among HIV isolates. The Gag p24 has been used as an integral part of multicomponent HIV-1 vaccines (3).

HIV-1 p24 Antibody [8G9] (HRP)
PM-6335-HRP-01mg	ProSci	0.1 mg	EUR 523.7
Description: HIV-1 p24 Monoclonal Antibody: The human immunodeficiency virus type 1 (HIV-1) particle consists of an envelope, a core and the region between the two termed matrix (1). The HIV-1 Gag protein is a late structural protein that contains four proteins: matrix (p17), capsid (p24), nucleocapsid (p7) and the p6 protein (2). The p24 constitutes the major core component of the virus and shows high degree of sequence conservation among HIV isolates. The Gag p24 has been used as an integral part of multicomponent HIV-1 vaccines (3).

HIV-1 p24 Antibody [7F4] (HRP)
PM-6585-HRP-002mg	ProSci	0.02 mg	EUR 206.18
Description: HIV-1 p24 Monoclonal Antibody: The human immunodeficiency virus type 1 (HIV-1) particle consists of an envelope, a core and the region between the two termed matrix (1). The HIV-1 Gag protein is a late structural protein that contains four proteins: matrix (p17), capsid (p24), nucleocapsid (p7) and the p6 protein (2). The p24 constitutes the major core component of the virus and shows high degree of sequence conservation among HIV isolates. The Gag p24 has been used as an integral part of multicomponent HIV-1 vaccines (3).

HIV-1 p24 Antibody [7F4] (HRP)
PM-6585-HRP-01mg	ProSci	0.1 mg	EUR 523.7
Description: HIV-1 p24 Monoclonal Antibody: The human immunodeficiency virus type 1 (HIV-1) particle consists of an envelope, a core and the region between the two termed matrix (1). The HIV-1 Gag protein is a late structural protein that contains four proteins: matrix (p17), capsid (p24), nucleocapsid (p7) and the p6 protein (2). The p24 constitutes the major core component of the virus and shows high degree of sequence conservation among HIV isolates. The Gag p24 has been used as an integral part of multicomponent HIV-1 vaccines (3).

HIV-1 p24 Antibody [8G9] (biotin)
PM-6335-biotin-002mg	ProSci	0.02 mg	EUR 206.18
Description: HIV-1 p24 Monoclonal Antibody: The human immunodeficiency virus type 1 (HIV-1) particle consists of an envelope, a core and the region between the two termed matrix (1). The HIV-1 Gag protein is a late structural protein that contains four proteins: matrix (p17), capsid (p24), nucleocapsid (p7) and the p6 protein (2). The p24 constitutes the major core component of the virus and shows high degree of sequence conservation among HIV isolates. The Gag p24 has been used as an integral part of multicomponent HIV-1 vaccines (3).

HIV-1 p24 Antibody [8G9] (biotin)
PM-6335-biotin-01mg	ProSci	0.1 mg	EUR 523.7
Description: HIV-1 p24 Monoclonal Antibody: The human immunodeficiency virus type 1 (HIV-1) particle consists of an envelope, a core and the region between the two termed matrix (1). The HIV-1 Gag protein is a late structural protein that contains four proteins: matrix (p17), capsid (p24), nucleocapsid (p7) and the p6 protein (2). The p24 constitutes the major core component of the virus and shows high degree of sequence conservation among HIV isolates. The Gag p24 has been used as an integral part of multicomponent HIV-1 vaccines (3).

HIV-1 p24 Antibody [7F4] (biotin)
PM-6585-biotin-002mg	ProSci	0.02 mg	EUR 206.18
Description: HIV-1 p24 Monoclonal Antibody: The human immunodeficiency virus type 1 (HIV-1) particle consists of an envelope, a core and the region between the two termed matrix (1). The HIV-1 Gag protein is a late structural protein that contains four proteins: matrix (p17), capsid (p24), nucleocapsid (p7) and the p6 protein (2). The p24 constitutes the major core component of the virus and shows high degree of sequence conservation among HIV isolates. The Gag p24 has been used as an integral part of multicomponent HIV-1 vaccines (3).

HIV-1 p24 Antibody [7F4] (biotin)
PM-6585-biotin-01mg	ProSci	0.1 mg	EUR 523.7
Description: HIV-1 p24 Monoclonal Antibody: The human immunodeficiency virus type 1 (HIV-1) particle consists of an envelope, a core and the region between the two termed matrix (1). The HIV-1 Gag protein is a late structural protein that contains four proteins: matrix (p17), capsid (p24), nucleocapsid (p7) and the p6 protein (2). The p24 constitutes the major core component of the virus and shows high degree of sequence conservation among HIV isolates. The Gag p24 has been used as an integral part of multicomponent HIV-1 vaccines (3).

HIV type O envelope antigen
00178-V-01mg	Virogen	0,1 mg	EUR 321
Description: HIV type O envelope antigen. Synthetic HIV type-O peptide, containing the HIV type-O envelope-derived sequence.

HIV type O envelope antigen
00178-V-1000ug	Virogen	1000 ug	EUR 1539
Description: HIV type O envelope antigen. Synthetic HIV type-O peptide, containing the HIV type-O envelope-derived sequence.

HIV 2 gp36 envelope antigen
00180-V-01mg	Virogen	0,1 mg	EUR 321
Description: HIV 2 gp36 envelope antigen. Synthetic HIV-2 Peptide containing the HIV-2 specific sequence of gp36.

HIV 2 gp36 envelope antigen
00180-V-1000ug	Virogen	1000 ug	EUR 1539
Description: HIV 2 gp36 envelope antigen. Synthetic HIV-2 Peptide containing the HIV-2 specific sequence of gp36.

Polyclonal HIV-1 p24 Antibody [7F4]
APR11117G	Leading Biology	0.1 mg	EUR 790.8
Description: A polyclonal antibody raised in Mouse that recognizes and binds to Human HIV-1 p24 [7F4] . This antibody is tested and proven to work in the following applications:

HIV 1, 2 envelope recombinant antigen. HIV-1 envelope conjugated to HIV-2 envelope peptide.
00175-V-100ugvial	Virogen	100ug/vial	EUR 150
Description: HIV 1, 2 envelope recombinant antigen. HIV-1 envelope conjugated to HIV-2 envelope peptide.

HIV-2 GP 36 Recombinant Antigen
00114-V-01mg	Virogen	0,1 mg	EUR 321
Description: HIV -2 env gp36 recombinant antigen a.a 390 to a.a 702 of the HIV-2 env region 34 kDa

HIV-2 GP 36 Recombinant Antigen
00114-V-1000ug	Virogen	1000 ug	EUR 1539
Description: HIV -2 env gp36 recombinant antigen a.a 390 to a.a 702 of the HIV-2 env region 34 kDa

HIV-1 p24, His tag
E410A26-20	EnoGene	20μg	EUR 520.8

HIV-1 p24 Core Protein
20-abx260141	Abbexa	EUR 1062.00 EUR 410.40 EUR 1646.40	0.5 mg 100 ug 1 mg

Mouse antibody for HIV-1 p24
1941	Virostat	100 ug	EUR 399.3
Description: This is purified Mouse monoclonal antibody against HIV-1 p24 for WB, ELISA.

Mouse antibody for HIV-1 p24
1946	Virostat	100 ug	EUR 425.4
Description: This is purified Mouse monoclonal antibody against HIV-1 p24 for WB, ELISA.

Mouse antibody for HIV-1 p24
1947	Virostat	100 ug	EUR 425.4
Description: This is purified Mouse monoclonal antibody against HIV-1 p24 for WB, ELISA.

Mouse antibody for HIV-1 p24
1948	Virostat	100 ug	EUR 425.4
Description: This is purified Mouse monoclonal antibody against HIV-1 p24 for WB, ELISA.

Mouse antibody for HIV-1 p24
1949	Virostat	100 ug	EUR 425.4
Description: This is purified Mouse monoclonal antibody against HIV-1 p24 for WB, ELISA.

Recombinant HIV-1 p24 Core
7-07597	CHI Scientific	100µg	Ask for price

Recombinant HIV-1 p24 Core
7-07598	CHI Scientific	500µg	Ask for price

Recombinant HIV-1 p24 Core
7-07599	CHI Scientific	1000µg	Ask for price

QuickTiter HIV Lentivirus Quantitation Kit (p24 ELISA)
VPK-108-H	Cell Biolabs	96 assays	EUR 866.4
Description: Quantitation of the HIV-1 p24 core protein of a lentiviral vector is an efficient, well-published method for determining lentivirus physical titer. The QuickTiter Lentivirus Quantitation Kits provide a convenient method of p24 antigen quantitation.

QuickTiter HIV Lentivirus Quantitation Kit (p24 ELISA)
VPK-108-H-5	Cell Biolabs	5 x 96 assays	EUR 3560.4
Description: Quantitation of the HIV-1 p24 core protein of a lentiviral vector is an efficient, well-published method for determining lentivirus physical titer. The QuickTiter Lentivirus Quantitation Kits provide a convenient method of p24 antigen quantitation.

Recombinant HIV-1 p24 , 24kDa
7-07621	CHI Scientific	2µg	Ask for price

Recombinant HIV-1 p24 , 24kDa
7-07622	CHI Scientific	10µg	Ask for price

Recombinant HIV-1 p24 , 24kDa
7-07623	CHI Scientific	100µg	Ask for price

HIV-1 p24 Recombinant Protein
53-341	ProSci	0.01 mg	EUR 789.9
Description: HIV-1 p24 Recombinant Protein

HIV-1 nef recombinant antigen a.a 3 to a.a 190 of the HIV-1 nef region 20 kDa
00112-V-100ugvial	Virogen	100ug/vial	EUR 150
Description: HIV-1 nef recombinant antigen a.a 3 to a.a 190 of the HIV-1 nef region 20 kDa

HIV-1 env gp41 recombinant antigen a.a 466 to a.a 753 of the HIV-1 env region 32 kDa
00113-V-100ugvial	Virogen	100ug/vial	EUR 150
Description: HIV-1 env gp41 recombinant antigen a.a 466 to a.a 753 of the HIV-1 env region 32 kDa

HIV -2 env gp36 recombinant antigen
00179-V-01mg	Virogen	0,1 mg	EUR 321
Description: HIV -2 env gp36 recombinant antigen. a.a 390 to a.a 702.

HIV -2 env gp36 recombinant antigen
00179-V-1000ug	Virogen	1000 ug	EUR 1539
Description: HIV -2 env gp36 recombinant antigen. a.a 390 to a.a 702.

HIV type 1 P24 [GST]
DAG1516	Creative Diagnostics	100 µg	EUR 774

HIV type 1 P24 [His]
DAG1518	Creative Diagnostics	100 µg	EUR 774

HIV type 1 P24 [His]
DAG1799	Creative Diagnostics	50 ug	EUR 2017.2

HIV type 1 P24 [His]
DAG2375	Creative Diagnostics	100 µg	EUR 868.8

HIV type 1 P24 [His]
DAG2377	Creative Diagnostics	100 µg	EUR 868.8

HIV-1 tat recombinant antigen full length 15 kDa
00110-V-100ugvial	Virogen	100ug/vial	EUR 150
Description: HIV-1 tat recombinant antigen full length 15 kDa

HIV-1 p24 Immune Complex Dissociation Kit
Z7040009	Biochain	1 kit	EUR 122

HIV type 1 p24 [FITC]
DAGH004	Creative Diagnostics	50 Tests	EUR 1112.4

HTLV-I p24 core recombinant antigen
00204-V-01mg	Virogen	0,1 mg	EUR 321
Description: HLTV-I p24 core recombinant antigen.

HTLV-I p24 core recombinant antigen
00204-V-1000ug	Virogen	1000 ug	EUR 1539
Description: HLTV-I p24 core recombinant antigen.

HLTV-I p24 core recombinant antigen.
00204-V-100ugvial	Virogen	100 ug/vial	EUR 150
Description: HLTV-I p24 core recombinant antigen.

HIV type 1 P24 [Biotin]
DAG1519	Creative Diagnostics	100 µg	EUR 972

Feline Immunodeficiency Virus p24 gag Antigen (FIV p24 gag) Antibody
abx413943-025mg	Abbexa	0.25 mg	EUR 811.2

HIV-1 gag p17, p24 Protein
20-abx260277	Abbexa	EUR 1062.00 EUR 410.40 EUR 1930.80	0.5 mg 100 ug 1 mg

HIV-1 p24, 24 kDa Protein
20-abx263118	Abbexa	EUR 1562.40 EUR 393.60 EUR 276.00	100 ug 10 ug 2 µg

Recombinant HIV-1 gag p17, p24
7-07675	CHI Scientific	100µg	Ask for price

Recombinant HIV-1 gag p17, p24
7-07676	CHI Scientific	500µg	Ask for price

Recombinant HIV-1 gag p17, p24
7-07677	CHI Scientific	1000µg	Ask for price

Felis p27 core antigen ELISA Kit
ELA-E1491FELA-E	Lifescience Market	96 Tests	EUR 1113.6

HIV-1 p24 Core, Sf9 Protein
20-abx260012	Abbexa	EUR 2815.20 EUR 493.20 EUR 276.00	100 ug 10 ug 2 µg

Mouse Monoclonal Anti- HIV-1 p24 IgG
AB-15210	Alpha Diagnostics	100 ug	EUR 416.4

Toxoplasma gondii P24 (GRA1) recombinant antigen
00207-V-01mg	Virogen	0,1 mg	EUR 321
Description: Toxoplasma gondii P24 (GRA1) recombinant antigen

Toxoplasma gondii P24 (GRA1) recombinant antigen
00207-V-1000ug	Virogen	1000 ug	EUR 1539
Description: Toxoplasma gondii P24 (GRA1) recombinant antigen

Toxoplasma gondii P24 (GRA1) recombinant antigen
00207-V-100ugvial	Virogen	100ug/vial	EUR 150
Description: Toxoplasma gondii P24 (GRA1) recombinant antigen

HIV-1 gp120 and gp41 Chimeric Antigen (16 kDa, Capture)
DAGF-220	Creative Diagnostics	1mg	EUR 817.2

HIV-1 gp120 and gp41 Chimeric Antigen (8 kDa, Capture)
DAGF-222	Creative Diagnostics	1mg	EUR 817.2

HIV-1 gp120 and gp41 Chimeric Antigen (45 kDa, Capture)
DAGF-224	Creative Diagnostics	1mg	EUR 817.2

Recombinant HIV-1 p24 His Tag
7-07606	CHI Scientific	5µg	Ask for price

Recombinant HIV-1 p24 His Tag
7-07607	CHI Scientific	20µg	Ask for price

Recombinant HIV-1 p24 His Tag
7-07608	CHI Scientific	1mg	Ask for price

Recombinant HIV-1 p24 Core, Sf9
7-07602	CHI Scientific	100µg	Ask for price

Recombinant HIV-1 p24 Core, Sf9
7-07600	CHI Scientific	2µg	Ask for price

Recombinant HIV-1 p24 Core, Sf9
7-07601	CHI Scientific	10µg	Ask for price

HIV-1 gp120 and gp41 Chimeric Antigen (43 kDa, Detection)
DAGF-223	Creative Diagnostics	1mg	EUR 817.2

HIV-1 p24, Biotin Labeled Protein
20-abx260358	Abbexa	EUR 1496.40 EUR 560.40 EUR 2364.00	0.5 mg 100 ug 1 mg

p24-HIV(p24/661) Antibody
BNCA0661-250	Biotium	250uL	EUR 459.6
Description: Primary antibody against p24-HIV(p24/661), APC conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody
BNC800661-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against p24-HIV(p24/661), CF680 conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody
BNC800661-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against p24-HIV(p24/661), CF680 conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody
BNC810661-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against p24-HIV(p24/661), CF680R conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody
BNC810661-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against p24-HIV(p24/661), CF680R conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody
BNC940661-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against p24-HIV(p24/661), CF594 conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody
BNC940661-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against p24-HIV(p24/661), CF594 conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody
BNC700661-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against p24-HIV(p24/661), CF770 conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody
BNC700661-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against p24-HIV(p24/661), CF770 conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody
BNC880661-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against p24-HIV(p24/661), CF488A conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody
BNC880661-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against p24-HIV(p24/661), CF488A conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody
BNC050661-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against p24-HIV(p24/661), CF405M conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody
BNC050661-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against p24-HIV(p24/661), CF405M conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody
BNC040661-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against p24-HIV(p24/661), CF405S conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody
BNC040661-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against p24-HIV(p24/661), CF405S conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody
BNC400661-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against p24-HIV(p24/661), CF640R conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody
BNC400661-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against p24-HIV(p24/661), CF640R conjugate, Concentration: 0.1mg/mL